02/04/2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
26/03/2024
Final Dividend for the Year Ended 31 December 2023
26/03/2024
Announcement of Annual Results for the Year Ended 31 December 2023
14/03/2024
Notice of Board Meeting
13/03/2024
Letter to Non-registered Shareholders – Arrangement for Electronic Dissemination of Corporate Communications and Reply Form
13/03/2024
Letter to Registered Shareholders – Arrangement for Electronic Dissemination of Corporate Communications and Reply Form
01/03/2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
01/02/2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
03/01/2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
01/12/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
28/11/2023
Voluntary Announcement – Adasuve Obtains Drug Registration Certificate
13/11/2023
Discloseable Transaction – Disposal of Assets
01/11/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
03/10/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
04/09/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
30/08/2023
Interim Dividend for the Six Months Ended 30 June 2023
30/08/2023
Interim Results for the Six Months Ended 30 June 2023
21/08/2023
Voluntary Announcement – Update on an Investigational Anesthesia Product
21/08/2023
Voluntary Announcement – Apremilast Tablet Obtains Drug Registration Certificate
21/08/2023
Profit Warning
21/08/2023
Supplemental Announcement Regarding Annual Report for the Year Ended 31 December 2022
18/08/2023
Notice of Board Meeting
01/08/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
06/07/2023
Change of Auditor
03/07/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
09/06/2023
Voluntary Announcement – INOmax DSIR Plus Delivery System Obtains Medical Device Registration Certificate
01/06/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
18/05/2023
Amended and Restated Memorandum and Articles of Association
17/05/2023
List of Directors and their Roles and Functions
17/05/2023
(1) Poll Result of Annual General Meeting held on 17 May 2023; (2) Resignation of an Independent Non-executive Director; (3) Appointment of an Independent Non-executive Director; and (4) Adoption of Amend and Restated Memorandum and Articles of Association
02/05/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
28/04/2023
Cessation of Quarterly Financial Results Publication
21/04/2023
Notice of Annual General Meeting
21/04/2023
General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors, Appointment of Independent Non-Executive Director, Adoption of Amended and Restated Memorandum and Articles of Association and Notice of Annual General Meeting
21/04/2023
Proxy Form
19/04/2023
Proposed Appointment of Independent Non-Executive Director
17/04/2023
Proposed Adoption of Amended and Restated Memorandum and Articles of Association
04/04/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
30/03/2023
Final Dividend for the year ended 31 December 2022
30/03/2023
Announcement of Annual Results for the year ended 31 December 2022
20/03/2023
Notice of Board Meeting
20/03/2023
Profit Warning
02/03/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
16/02/2023
Voluntary Announcement – Business Update on the Extended Phase 2b Study of Tafoxiparin by Dilafor
01/02/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
19/01/2023
Voluntary Announcement – Inclusion of Treprostinil Injection, Teglutik and Trittico in the National Reimbursement Drug List
03/01/2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
16/12/2022
Terms of Reference of the Remuneration Committee
02/12/2022
Grant of Share Options
01/12/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
17/11/2022
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2022
09/11/2022
Voluntary Announcement – Approval of a Drug Product Manufactured by Zhaoke Guangzhou to Conduct Clinical Trial in the United States
04/11/2022
Notice of Board Meeting
01/11/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
26/10/2022
Voluntary Announcement – Completion of Patient Enrolment for a Phase III Clinical Trial of Intrarosa
03/10/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
29/09/2022
Voluntary Announcement – Obtaining Drug Marketing Authorisation of Azilsartan Tablets
22/09/2022
Discloseable Transaction – Disposal of Equity Interest in a Subsidiary
01/09/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
26/08/2022
Interim Dividend for the Six Months Ended 30 June 2022
26/08/2022
Interim Results for the Six Months Ended 30 June 2022
23/08/2022
Voluntary Announcement – Obtains Global License of SURFAXIN, SURFAXIN LS and AEROSURF from Windtree Therapeutics, Inc.
16/08/2022
Notice of Board Meeting
15/08/2022
Profit Warning
01/08/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
04/07/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
21/06/2022
Voluntary Announcement – Teglutik Obtains Drug Registration Certificate
01/06/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
26/05/2022
First Quarterly Results Announcement for the Three Months Ended 31 March 2022
20/05/2022
Supplemental Announcement in relation to the Poll Results of Annual General Meeting held on 19 May 2022
19/05/2022
Voluntary Announcement – Natulan Obtains Drug Registration Certificate
19/05/2022
Annual General Meeting Held on 19 May 2022 – Poll Results
16/05/2022
Notice of Board Meeting
13/05/2022
Voluntary Announcement – Update on an Investigational Oncology Drug Product
04/05/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
25/04/2022
Grant of Share Options
21/04/2022
Share Option Scheme
21/04/2022
Proxy Form
21/04/2022
Notice of Annual General Meeting
21/04/2022
General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors, Adoption of New Share Option Scheme, Adoption of Amended and Restated Memorandum and Articles of Association and Notice of Annual General Meeting
21/04/2022
Voluntary Announcement – INOmax obtains Drug Registration Certificate
06/04/2022
Proposed Adoption of New Share Option Scheme and Proposed Adoption of Amended and Restated Memorandum and Articles of Association
01/04/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
29/03/2022
Final Dividend for the year ended 31 December 2021
29/03/2022
Announcement of Annual Results for the year ended 31 December 2021
17/03/2022
Notice of Board Meeting
04/02/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
04/01/2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
02/01/2022
List of Directors and their Roles and Functions
02/01/2022
Terms of Reference of the Nomination Committee
02/01/2022
Appointment of Non-executive Director and Establishment of Nomination Committee
01/12/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
25/11/2021
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2021
16/11/2021
Voluntary Announcement – Update on an Investigational Oncology Drug Product
15/11/2021
Notice of Board Meeting
02/11/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
02/11/2021
Supplemental Announcement Regarding Annual Report for the Year Ended 31 December 2020
27/10/2021
Voluntary Announcement – Business Update on the In-Licensing and Research and Development of Tafoxiparin of the Group
27/10/2021
Voluntary Announcement – New Drug Application of Socazolimab for Treatment of Recurrent or Metastatic Cervical Cancer Submitted and Accepted by NMPA
04/10/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
04/10/2021
Voluntary Announcement – Update on the Commercialisation and Research and Development of Cetraxal Plus of the Group
27/09/2021
Voluntary Announcement – Update on the Research and Development of an Investigational Oncology Product
13/09/2021
Voluntary Announcement – Update on an Investigational Gynecology Drug Product
01/09/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
01/09/2021
Voluntary Announcement – Appointment of Chief Medical Officer
26/08/2021
Interim Dividend for the Six Months Ended 30 June 2021
26/08/2021
Interim Results for the Six Months Ended 30 June 2021
16/08/2021
Notice of Board Meeting
13/08/2021
Positive Profit Alert
05/08/2021
Voluntary Announcement – Business Update on an Investigational Continuous Glucose Monitoring System of an Associated Company of the Group
02/08/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
22/07/2021
Voluntary Announcement – Update on an Investigational Oncology Drug Product
16/07/2021
Connected Transaction – Provision of Financial Assistance
02/07/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021
30/06/2021
List of Directors and their Roles and Functions
30/06/2021
Resignation of Non-Executive Director
21/06/2021
Voluntary Announcement – Business Update on the Licensed-in of Bredinin from Asahi Kasei Pharma Corporation
07/06/2021
Voluntary Announcement – Official Release of the Result of Phase I Clinical Trial on the Safety and Antithrombotic Efficacy of Anfibatide
02/06/2021
Voluntary Announcement – Business Update on the In-licensing and Research and Development of Tafoxiparin of the Group
01/06/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021
28/05/2021
Connected Transaction – Provision of Financial Assistance
27/05/2021
First Quarterly Results Announcement for the Three Months Ended 31 March 2021
24/05/2021
Annual General Meeting Held on 24 May 2021 – Poll Results
21/05/2021
Voluntary Announcement – Sodium Phenylbutyrate Granules Obtained Approval for Drug Registration
14/05/2021
Notice of Board Meeting
03/05/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
29/04/2021
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange – Listing of Zhaoke Ophthalmology and Commencement of Dealings
29/04/2021
List of Directors and their Role and Function
29/04/2021
Terms of Reference of the Management Committee
29/04/2021
(1) Establishment of Management Committee; (2) Resignation of Chief Executive Officer and Re-designation of Director; and (3) Change of Authorised Representative
28/04/2021
Connected Transaction – Provision of Financial Assistance
28/04/2021
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange – Final Offer Price
21/04/2021
Grant of Share Options
21/04/2021
Proxy Form
21/04/2021
General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors, and Notice of Annual General Meeting
21/04/2021
Notice of Annual General Meeting
16/04/2021
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange – Publication of The Prospectus and Expected Size of The Global Offering and Offer Price Range
12/04/2021
Voluntary Announcement – Update on Research and Development of an Investigational Ophthalmology Product of an Associated Company of the Group
07/04/2021
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange – Post Hearing Information Pack
01/04/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
30/03/2021
Announcement of Annual Results for the year ended 31 December 2020
26/03/2021
Connected Transaction – Provision of Financial Assistance
23/03/2021
Update on The Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange – Record Date, Closure of Register of Members and Basis of The Assured Entitlement of Qualifying Shareholders in The Preferential Offering
18/03/2021
Notice of Board Meeting
15/03/2021
Extraordinary General Meeting Held on 15 March 2021 – Poll Results
11/03/2021
Voluntary Announcement – Update on an Investigational Direct Oral Anticoagulant
11/03/2021
Voluntary Announcement – Update on an Investigational Ophthalmology Product of an Associated Company of the Group
05/03/2021
Voluntary Announcement – Socazolimab Obtained Approval for a Phase III Clinical Trial from NMPA
04/03/2021
Voluntary Announcement – Update of Business Development with KPC Pharmaceuticals, Inc.
01/03/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
24/02/2021
Notice of Extraordinary General Meeting
24/02/2021
Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange and Notice of Extraordinary General Meeting
24/02/2021
Proxy Form for use by Shareholders at the Extraordinary General Meeting
11/02/2021
Further Delay in Despatch of Circular – Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange
09/02/2021
Voluntary Announcement – Update on the Research and Development of an Investigational Oncology Product
09/02/2021
Voluntary Announcement – Update on an Investigational Dermatology Product
05/02/2021
Voluntary Announcement – Fondaparinux Sodium Injection Obtained Approval for Drug Registration
05/02/2021
Voluntary Announcement – Update on an Investigational Oncology Product
02/02/2021
Voluntary Announcement – Memorandum of Understanding of an Associated Company in relation to the Strategic Partnership with Singapore Eye Research Institute
01/02/2021
Connected Transaction – Provision of Financial Assistance
01/02/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
29/01/2021
Delay in Despatch of Circular – Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange
15/01/2021
Voluntary Announcement – Update on an Investigational Gynecology Drug Product
13/01/2021
Voluntary Announcement – Update on an Investigational Ear Drug Product
04/01/2021
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
29/12/2020
Voluntary Announcement – Update on Research and Development of an Investigational Ophthalmology Product of an Associated Company of the Group
18/12/2020
Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange
11/12/2020
Voluntary Announcement – Trazodone Hydrochloride Tablet Obtained Drug Registration Certificate from China’s National Medical Products Administration
01/12/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
30/11/2020
Voluntary Announcement – Update on Research and Development of an Investigational Ophthalmology Product of an Associated Company of the Group
26/11/2020
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2020
20/11/2020
Voluntary Announcement – Update on the Possible Spin-Off and Separate Listing of Zhaoke Ophthalmology Limited
18/11/2020
Connected Transaction – Provision of Financial Assistance
17/11/2020
Voluntary Announcement – Completion of Series B Shares Subscription in an Associated Company
16/11/2020
Notice of Board Meeting
16/11/2020
Voluntary Announcement – Business Update on the In-Licensing and Research and Development of Ophthalmology Products of an Associated Company of the Group
06/11/2020
Voluntary Announcement – Update on an Investigational Anaesthesia Product
02/11/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
23/10/2020
Grant of Share Options
23/10/2020
Voluntary Announcement – Establishment of the Group Commercial Operations Centre
20/10/2020
Voluntary Announcement – Business Update on the In-Licensing and Research and Development of Ophthalmology Products of an Associated Company of the Group
11/10/2020
Voluntary Announcement – Reduction in Equity Interest in an Associated Company
05/10/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020
04/10/2020
Discloseable Transaction – License Agreement in relation to Licensed Rights and Disposal of Equity Interest in a Subsidiary
25/09/2020
Connected Transaction – Provision of Financial Assistance
03/09/2020
Voluntary Announcement – Update on an Investigational Inhaled Antipsychotic Product
03/09/2020
Voluntary Announcement – Update on the Possible Spin-off and Separate Listing of China Ophthalmology Focus Limited
01/09/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020
31/08/2020
Voluntary Announcement – Update on an Investigational Anaesthesia Product
28/08/2020
Forfeiture of Unclaimed Dividends
27/08/2020
Interim Results for the Six Months Ended 30 June 2020
21/08/2020
Voluntary Announcement – Update on the Introduction and Research and Development of an Investigational Oncology Product
20/08/2020
Supplemental Announcement regarding Annual Report for the year ended 31 December 2019
17/08/2020
Notice of Board Meeting
13/08/2020
Positive Profit Alert
06/08/2020
Voluntary Announcement – Nadroparin Calcium for Injection obtained Drug Registration Approval
03/08/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2020
17/07/2020
Connected Transaction – Provision of Financial Assistance
17/07/2020
Connected Transaction – Provision of Financial Assistance
16/07/2020
Voluntary Announcement – Update on the Introduction and Research and Development of an Investigational Oncology Product
13/07/2020
Voluntary Announcement – Update on an Investigational Inhaled Antipsychotic Product
09/07/2020
Voluntary Announcement – Possible Spin-off and Separate Listing of China Ophthalmology Focus Limited
02/07/2020
Voluntary Announcement – Update on the In-Licensing and Research and Development of Ophthalmology Products
02/07/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2020
26/06/2020
Voluntary Announcement – Unidrox Prulifloxacin Tablet Obtained Imported Drug License from China’s National Medical Products Administration
22/06/2020
Voluntary Announcement – Update on an Investigational Dermatology Product
12/06/2020
Connected Transaction – Provision of Financial Assistance
01/06/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
26/05/2020
First Quarterly Results Announcement for the Three Months Ended 31 March 2020
21/05/2020
Annual General Meeting Held on 21 May 2020 – Poll Results
18/05/2020
Connected Transaction – Provision of Financial Assistance
14/05/2020
Notice of Board Meeting
12/05/2020
Voluntary Announcement – Update on an Investigational Inhaled Antipsychotic Product
08/05/2020
Voluntary Announcement – Update on an Investigational Oncology Product
08/05/2020
Voluntary Announcement – Update on the In-Licensing and Research and Development of Ophthalmology Products
04/05/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
17/04/2020
Proxy Form
17/04/2020
Notice of Annual General Meeting
17/04/2020
General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors, and Notice of Annual General Meeting
15/04/2020
Grant of Share Options
14/04/2020
Voluntary Announcement – Appointment of Chief Strategy Officer specialising in Ophthalmology
14/04/2020
Voluntary Announcement – Update on an Investigational Dermatology Product
01/04/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2020
27/03/2020
Connected Transaction – Provision of Financial Assistance
26/03/2020
Announcement of Annual Results for the year ended 31 December 2019
24/03/2020
Connected Transaction – Provision of Financial Assistance
19/03/2020
Voluntary Announcement – Treprostinil Injection Obtained Approval for Drug Registration
16/03/2020
Voluntary Announcement – Update on an Inhalation Gas Product
16/03/2020
Profit Warning
16/03/2020
Notice of Board Meeting
10/03/2020
Voluntary Announcement – Aliskiren Combined with Nifedipine Obtained Approval from West China Hospital Biomedical Ethics Committee of Sichuan University to Conduct Clinical Trial on the Treatment of Hypertension Patient with Confirmed COVID-19 Pneumonia
10/03/2020
Voluntary Announcement – Business Update of an Associated Company of the Group
02/03/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2020
13/02/2020
Connected Transaction – Subscription for Shares in a Connected Subsidiary
11/02/2020
Continuing Connected Transaction – Provision of Financial Assistance
06/02/2020
Voluntary Announcement – Update of Business Development with Italfarmaco
03/02/2020
Voluntary Announcement – Update on Business Development
03/02/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2020
13/01/2020
Voluntary Announcement – Update on an Investigational Ophthalmology Product
02/01/2020
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019
03/12/2019
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2019
28/11/2019
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2019
22/11/2019
Voluntary Announcement – Update on the Introduction and Research and Development of an Investigational Dermatology Product
20/11/2019
Supplemental Announcement in relation to Connected Transaction
18/11/2019
Connected Transaction – Provision of Financial Assistance
15/11/2019
Notice of Board Meeting
05/11/2019
Next Day Disclosure Return
01/11/2019
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2019
30/10/2019
Voluntary Announcement – Update on the Introduction and Research and Development of an Investigational Ophthalmology Product
28/10/2019
Next Day Disclosure Return
23/10/2019
Next Day Disclosure Return
22/10/2019
Next Day Disclosure Return
21/10/2019
Next Day Disclosure Return
18/10/2019
Next Day Disclosure Return
17/10/2019
Next Day Disclosure Return
16/10/2019
Next Day Disclosure Return
15/10/2019
Next Day Disclosure Return
14/10/2019
Next Day Disclosure Return
11/10/2019
Next Day Disclosure Return
10/10/2019
Next Day Disclosure Return
09/10/2019
Next Day Disclosure Return
08/10/2019
Next Day Disclosure Return
04/10/2019
Next Day Disclosure Return
03/10/2019
Next Day Disclosure Return
03/10/2019
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2019
02/10/2019
Next Day Disclosure Return
30/09/2019
Next Day Disclosure Return
27/09/2019
Connected Transaction – Provision of Financial Assistance
27/09/2019
Next Day Disclosure Return
26/09/2019
Next Day Disclosure Return
24/09/2019
Next Day Disclosure Return
23/09/2019
Next Day Disclosure Return
20/09/2019
Next Day Disclosure Return
19/09/2019
Next Day Disclosure Return
18/09/2019
Next Day Disclosure Return
17/09/2019
Next Day Disclosure Return
13/09/2019
Interim Report 2019
06/09/2019
Honoured with “Most Innovative Small And Medium-Sized Pharmaceutical Enterprises Award in The Asia Pacific Region 2019” By Clarivate Analytics
04/09/2019
Forfeiture of unclaimed dividends
02/09/2019
Voluntary Announcement – Share Repurchase Program under the Repurchase Mandate
02/09/2019
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2019
29/08/2019
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2019
15/08/2019
NOTICE OF BOARD MEETING
13/08/2019
PROFIT WARNING
05/08/2019
INSIDE INFORMATION – UPDATE ON THE RESEARCH AND DEVELOPMENT OF AN INVESTIGATIONAL ONCOLOGY PRODUCT
02/08/2019
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2019
19/07/2019
CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
02/07/2019
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2019
14/06/2019
CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
05/06/2019
FIRST QUARTERLY REPORT 2019
03/06/2019
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2019
30/05/2019
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2019
23/05/2019
DEEMED DISPOSAL OF EQUITY INTERESTS IN A SUBSIDIARY
20/05/2019
NOTICE OF BOARD MEETING
20/05/2019
ANNUAL GENERAL MEETING HELD ON 20 MAY 2019 – POLL RESULTS
03/05/2019
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2019
15/04/2019
GRANT OF SHARE OPTIONS
12/04/2019
PROXY FORM
12/04/2019
NOTICE OF ANNUAL GENERAL MEETING
12/04/2019
GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
01/04/2019
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2019
28/03/2019
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
27/03/2019
CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
18/03/2019
NOTICE OF BOARD MEETING
14/03/2019
CONTINUING CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
05/03/2019
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2019
04/03/2019
POSITIVE PROFIT ALERT
01/02/2019
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2019
02/01/2019
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
02/01/2019
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2018
23/12/2018
ACQUISITION OF EQUITY INTEREST IN THE TARGET COMPANY AND DEEMED DISPOSALS OF EQUITY INTEREST IN WTI
20/12/2018
VOLUNTARY ANNOUNCEMENT – COLLABORATION AND LICENSE AGREEMENT WITH AURANSA
07/12/2018
CONTINUING CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
03/12/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2018
29/11/2018
CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
29/11/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON THE RESEARCH AND DEVELOPMENT OF A NOVEL PERCUTANEOUS OPTICAL FIBRE CONTINUOUS GLUCOSE SENSOR
29/11/2018
THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2018
19/11/2018
NOTICE OF BOARD MEETING
01/11/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2018
22/10/2018
CONNECTED TRANSACTION – SUBSCRIPTION FOR SHARES IN A CONNECTED SUBSIDIARY
10/10/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON THE INTRODUCTION AND RESEARCH AND DEVELOPMENT OF AN INVESTIGATIONAL ONCOLOGY PRODUCT
03/10/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2018
28/09/2018
CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
10/09/2018
VOLUNTARY ANNOUNCEMENT – INCLUSION IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHENZHEN-HONG KONG STOCK CONNECT
07/09/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON THE INTRODUCTION AND RESEARCH AND DEVELOPMENT OF AN INVESTIGATIONAL ONCOLOGY PRODUCT
05/09/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2018
31/08/2018
CLARIFICATION ANNOUNCEMENT – CLOSURE OF REGISTER OF MEMBERS
30/08/2018
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018
29/08/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON THE INTRODUCTION AND RESEARCH AND DEVELOPMENT OF AN INVESTIGATIONAL ANTICOAGULANT
16/08/2018
NOTICE OF BOARD MEETING
16/08/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON A GRANISETRON TRANSDERMAL PATCH PRODUCT
02/08/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2018
20/07/2018
CONNECTED TRANSACTIONS – DISPOSAL OF ASSETS
20/07/2018
CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
10/07/2018
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2017
09/07/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON AN INVESTIGATIONAL ANAESTHESIA PRODUCT
05/07/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2018
26/06/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON AN INVESTIGATIONAL OPHTHALMOLOGY PRODUCT
15/06/2018
CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
14/06/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON AN INVESTIGATIONAL ONCOLOGY PRODUCT
14/06/2018
CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
04/06/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2018
28/05/2018
CHANGE OF ADDRESS OF HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG
28/05/2018
CONNECTED TRANSACTION – PROVISIONS OF FINANCIAL ASSISTANCE
24/05/2018
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2018
23/05/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON THE INTRODUCTION AND RESEARCH AND DEVELOPMENT OF AN INVESTIGATIONAL ONCOLOGY
15/05/2018
ANNUAL GENERAL MEETING HELD ON 15 MAY 2018 – POLL RESULTS
03/05/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2018
24/04/2018
CONNECTED TRANSACTION – PROVISION OF FINANCIAL ASSISTANCE
13/04/2018
GRANT OF SHARE OPTIONS
11/04/2018
NOTICE OF ANNUAL GENERAL MEETING
11/04/2018
PROXY FORM
11/04/2018
GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
03/04/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2018
28/03/2018
CONNECTED TRANSACTION-PROVISION OF FINANCIAL ASSISTANCE
22/03/2018
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2017
14/03/2018
CONNECTED TRANSACTION – SUBSCRIPTION OF SHARES IN A CONNECTED SUBSIDIARY
12/03/2018
NOTICE OF BOARD MEETING
02/03/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2018
14/02/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON THE LICENSING IN AND RESEARCH AND DEVELOPMENT OF AN INVESTIGATIONAL ANTICOAGULANT
02/02/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2018
29/01/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON THE LICENSED-IN AND RESEARCH AND DEVELOPMENT OF AN ONCOLOGY PRODUCT
29/01/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON THE LICENSED-IN AND RESEARCH AND DEVELOPMENT OF AN ANTIHYPERTENSIVE DRUG
26/01/2018
VOLUNTARY ANNOUNCEMENT – UPDATE ON THE LICENSED-IN AND RESEARCH AND DEVELOPMENT OF A NEEDLE-FREE PERCUTANEOUS INJECTION DRUG DELIVERY SYSTEM PRODUCT
03/01/2018
PAST CONNECTED TRANSACTIONS – SUBSCRIPTIONS OF SHARES IN A CONNECTED SUBSIDIARY
03/01/2018
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2017
29/12/2017
CONNECTED TRANSACTION-PROVISION OF FINANCIAL ASSISTANCE
29/12/2017
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
29/12/2017
RESIGNATION AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR
01/12/2017
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2017
23/11/2017
THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2017
13/11/2017
NOTICE OF BOARD MEETING
02/11/2017
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2017
03/10/2017
GRANT OF SHARE OPTIONS
03/10/2017
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2017
04/09/2017
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2017
24/08/2017
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017
14/08/2017
NOTICE OF BOARD MEETING
01/08/2017
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2017
21/07/2017
CONNECTED AND CONTINUING CONNECTED TRANSACTIONS – PROVISION OF FINANCIAL ASSISTANCE
10/07/2017
ENVIRONMENTAL, SOCIAL, GOVERNANCE REPORT 2016
03/07/2017
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2017
13/06/2017
CONNECTED TRANSACTION-PROVISION OF FINANCIAL ASSISTANCE
02/06/2017
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2017
31/05/2017
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2017
17/05/2017
NOTICE OF BOARD MEETING
17/05/2017
ANNUAL GENERAL MEETING HELD ON 17 MAY 2017 – POLL RESULTS
02/05/2017
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2017
26/04/2017
FURTHER ANNOUNCEMENT IN RELATION TO CONNECTED TRANSACTION-PROVISION OF FINANCIAL ASSISTANCE
25/04/2017
CONNECTED TRANSACTION-PROVISION OF FINANCIAL ASSISTANCE
13/04/2017
GRANT OF SHARE OPTIONS
11/04/2017
NOTICE OF ANNUAL GENERAL MEETING
11/04/2017
PROXY FORM
11/04/2017
GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
06/04/2017
CLARIFICATION ANNOUNCEMENT IN RELATION TO INSIDE INFORMATION DISPOSAL OF SHARES BY SUBSTANTIAL SHAREHOLDER
03/04/2017
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2017
03/04/2017
INSIDE INFORMATION DISPOSAL OF SHARES BY SUBSTANTIAL SHAREHOLDER
23/03/2017
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016
13/03/2017
Notice of Board Meeting
02/03/2017
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2017
01/02/2017
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2017
03/01/2017
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2016
01/12/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2016
24/11/2016
THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2016
14/11/2016
NOTICE OF BOARD MEETING
01/11/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2016
03/10/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2016
01/09/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2016
25/08/2016
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2016
15/08/2016
NOTICE OF BOARD MEETING
01/08/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2016
04/07/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2016
13/06/2016
CONNECTED TRANSACTION-PROVISION OF FINANCIAL ASSISTANCE
01/06/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2016
26/05/2016
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2016
16/05/2016
NOTICE OF BOARD MEETING
16/05/2016
ANNUAL GENERAL MEETING HELD ON 16 MAY 2016 – POLL RESULTS
03/05/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2016
14/04/2016
NOTICE OF ANNUAL GENERAL MEETING
14/04/2016
PROXY FORM
14/04/2016
GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
11/04/2016
CHANGE OF DATE OF ANNUAL GENERAL MEETING AND PERIOD OF CLOSURE OF REGISTER OF MEMBERS
01/04/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2016
31/03/2016
GRANT OF SHARE OPTIONS
23/03/2016
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015
11/03/2016
NOTICE OF BOARD MEETING
02/03/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2016
02/02/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2016
13/01/2016
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
04/01/2016
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2015
01/12/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2015
25/11/2015
THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2015
13/11/2015
NOTICE OF BOARD MEETING
02/11/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2015
02/10/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2015
08/09/2015
DISCLOSEABLE TRANSACTION-ACQUISITION OF TARGET LAND PARCEL IN THE PRC
01/09/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2015
27/08/2015
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2015
21/08/2015
CONNECTED TRANSACTION-THE ESTABLISHMENT OF AN INVESTMENT FUND AND SUBSCRIPTION OF THE INTEREST IN THE FUND
17/08/2015
NOTICE OF BOARD MEETING
03/08/2015
CLARIFICATION ANNOUNCEMENT IN RELATION TO ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2014
03/08/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2015
02/07/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2015
17/06/2015
NEXT DAY DISCLOSURE RETURN
12/06/2015
NEXT DAY DISCLOSURE RETURN
01/06/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2015
28/05/2015
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2015
15/05/2015
NOTICE OF BOARD MEETING
11/05/2015
ANNUAL GENERAL MEETING HELD ON 11 MAY 2015 – POLL RESULTS
04/05/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2015
22/04/2015
NEXT DAY DISCLOSURE RETURN
22/04/2015
COMPLETION OF THE PLACING OF NEW SHARES UNDER GENERAL MANDATE
15/04/2015
PLACING OF NEW SHARES UNDER GENERAL MANDATE
02/04/2015
NOTICE OF ANNUAL GENERAL MEETING
02/04/2015
PROXY FORM
02/04/2015
GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
01/04/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2015
31/03/2015
GRANT OF SHARE OPTIONS
26/03/2015
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
13/03/2015
CONNECTED TRANSACTION-PROVISION OF FINANCIAL ASSISTANCE
13/03/2015
NOTICE OF BOARD MEETING
04/03/2015
NEXT DAY DISCLOSURE RETURN
02/03/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2015
02/02/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2015
06/01/2015
CONNECTED TRANSACTION-PROVISION OF FINANCIAL ASSISTANCE
02/01/2015
NEXT DAY DISCLOSURE RETURN
02/01/2015
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2014
29/12/2014
LIST OF DIRECTORS THEIR ROLE AND FUNCTION
29/12/2014
RESIGNATION AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR
08/12/2014
CLARIFICATION ANNOUNCEMENT
03/12/2014
SHARE TRANSACTION
01/12/2014
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2014
27/11/2014
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2014
17/11/2014
Notice of Board Meeting
03/11/2014
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2014
07/10/2014
Grant of Share Options
07/10/2014
CHANGE OF CHIEF FINANCIAL OFFICER AND COMPANY SECRETARY
03/10/2014
Monthly Return on Movements in Securities for the month ended 30/9/2014
30/09/2014
CONNECTED TRANSACTION- PROVISION OF FINANCIAL ASSISTANCE
02/09/2014
CHANGE IN BOARD LOT SIZE
01/09/2014
Monthly Return on Movements in Securities for the month ended 31/8/2014
25/08/2014
Interim Results for the six months ended 30 June 2014
12/08/2014
Notice of Board Meeting
06/08/2014
Monthly Return on Movements in Securities for the month ended 31/7/2014
24/07/2014
CONNECTED TRANSACTION- PROVISION OF FINANCIAL ASSISTANCE
02/07/2014
Monthly Return on Movements in Securities for the month ended 30/6/2014
24/06/2014
Next day disclosure returns – issue of share
03/06/2014
Monthly Return on Movements in Securities for the month ended 31/5/2014
26/05/2014
First Quarterly Results Announcement for the Three Months Ended 31 March 2014
12/05/2014
Notice of Board Meeting
12/05/2014
Poll Results at Annual General Meeting
07/05/2014
Continuing Connected Transactions
02/05/2014
Monthly Return on Movements in Securities for the month ended 30/4/2014
24/04/2014
ANNOUNCEMENT
01/04/2014
Monthly Return on Movements in Securities for the month ended 31/3/2014
25/03/2014
Proxy Forms
25/03/2014
Circular-General mandates to issue shares and repurchase its own shares and reelection of directors
20/03/2014
Notice of Annual General Meeting
20/03/2014
Final Results Announcement for the year ended 31 December 2013
06/03/2014
Notice of Board Meeting
03/03/2014
Monthly Return on Movements in Securities for the month ended 28/2/2014
04/02/2014
Monthly Return on Movements in Securities for the month ended 31/1/2014
02/01/2014
Monthly Return on Movements in Securities for the month ended 31/12/2013
30/12/2013
Grant of options
20/12/2013
CONNECTED TRANSACTION- PROVISION OF FINANCIAL ASSISTANCE
18/12/2013
Next day disclosure returns – issue of share
11/12/2013
Connected Transactions
02/12/2013
Monthly Return on Movements in Securities for the month ended 30/11/2013
27/11/2013
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2013
13/11/2013
Notice of Board Meeting
01/11/2013
Monthly Return on Movements in Securities for the month ended 31/10/2013
15/10/2013
Continuing Connected Transactions
07/10/2013
CONNECTED TRANSACTION- PROVISION OF FINANCIAL ASSISTANCE
02/10/2013
Monthly Return on Movements in Securities for the month ended 30/09/2013
02/09/2013
Monthly Return on Movements in Securities for the month ended 31/08/2013
30/08/2013
Interim Report 2013
28/08/2013
Interim Results for the six months ended 30 June 2013
26/08/2013
SUPPLEMENTAL ANNOUNCEMENT CONNECTED TRANSACTION AND DISCLOSEABLE TRANSACTION
12/08/2013
CONNECTED TRANSACTION AND DISCLOSEABLE TRANSACTION
09/08/2013
Notice of Board Meeting
02/08/2013
Monthly Return on Movements in Securities for the month ended 31/07/2013
23/07/2013
CONNECTED TRANSACTION- PROVISION OF FINANCIAL ASSISTANCE
02/07/2013
Next day disclosure returns – issue of share
02/07/2013
Monthly Return on Movements in Securities for the month ended 30/06/2013
20/06/2013
Next day disclosure returns – issue of share
19/06/2013
CONNECTED TRANSACTION- PROVISION OF FINANCIAL ASSISTANCE
03/06/2013
Monthly Return on Movements in Securities for the month ended 31/05/2013
23/05/2013
POSTPONEMENT OF SHARE TRANSACTION
20/05/2013
First Quarterly Results Announcement for the Three Months Ended 31 March 2013
09/05/2013
Poll Results at Annual General Meeting
02/05/2013
Notice of Board Meeting
02/05/2013
Monthly Return on Movements in Securities for the month ended 30/04/2013
24/04/2013
Share Transaction
10/04/2013
Next day disclosure returns – issue of share
05/04/2013
Grant of options
02/04/2013
Monthly Return on Movements in Securities for the month ended 31/03/2013
25/03/2013
Proxy Forms
25/03/2013
Circular-General mandates to issue shares and repurchase its own shares and reelection of directors
20/03/2013
Notice of Annual General Meeting
20/03/2013
Final Results Announcement for the year ended 31 December 2012
04/03/2013
Notice of Board Meeting
01/03/2013
CONNECTED TRANSACTION
01/03/2013
Monthly Return on Movements in Securities for the month ended 28/02/2013
26/02/2013
REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS
01/02/2013
Monthly Return on Movements in Securities for the month ended 31/01/2013
23/01/2013
CHANGE OF AUDITORS
21/01/2013
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING
04/01/2013
CONNECTED TRANSACTION- PROVISION OF FINANCIAL ASSISTANCE
03/01/2013
Monthly Return on Movements in Securities for the month ended 31/12/2012
20/12/2012
Grant of options
20/12/2012
Form of proxy for use at the Extraordinary General Meeting
20/12/2012
Circular – Continuing Connected Transaction
20/12/2012
Notice of Extraordinary General Meeting
03/12/2012
Monthly Return on Movements in Securities for the month ended 30/11/2012
30/11/2012
CONTINUING CONNECTED TRANSACTION
30/11/2012
GRANT OF SHARE OPTIONS UNDER A SUBSIDIARY SHARE OPTION SCHEME
26/11/2012
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2012
23/11/2012
CONTINUING CONNECTED TRANSACTION
12/11/2012
Notice of Board Meeting
12/11/2012
Poll Results of Extraordinary General Meeting
06/11/2012
Next day disclosure returns – issue of share
05/11/2012
Monthly Return on Movements in Securities for the month ended 31/10/2012
11/10/2012
Form of proxy for use at the Extraordinary General Meeting
11/10/2012
Adoption of share option scheme of a subsidiary
10/10/2012
Notice of Extraordinary General Meeting
08/10/2012
Grant of options
03/10/2012
Monthly Return on Movements in Securities for the month ended 30/09/2012
03/09/2012
Monthly Return on Movements in Securities for the month ended 31/08/2012
27/08/2012
Interim Results for the six months ended 30 June 2012
09/08/2012
Notice of Board Meeting
01/08/2012
Monthly Return on Movements in Securities for the month ended 31/07/2012
24/07/2012
POSITIVE PROFIT ALERT
23/07/2012
CONNECTED TRANSACTION- PROVISION OF FINANCIAL ASSISTANCE
10/07/2012
Next day disclosure returns – issue of share
06/07/2012
Discloseable Transactions
03/07/2012
Monthly Return on Movements in Securities for the month ended 30/06/2012
06/06/2012
Next day disclosure returns – issue of share
01/06/2012
Monthly Return on Movements in Securities for the month ended 31/05/2012
28/05/2012
CLARIFICATION ANNOUNCEMENT
25/05/2012
PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION FOR NEW SHARES UNDER GENERAL MANDATE
25/05/2012
CONTINUING CONNECTED TRANSACTIONS
24/05/2012
Placing of Existing Shares and Top-up Subscription for New Shares
21/05/2012
First Quarterly Results Announcement for the Three Months Ended 31 March 2012
10/05/2012
Poll Results at Annual General Meeting
07/05/2012
Notice of Board Meeting
02/05/2012
Monthly Return on Movements in Securities for the month ended 30/04/2012
23/04/2012
POSITIVE PROFIT ALERT
02/04/2012
Monthly Return on Movements in Securities for the month ended 31/03/2012
27/03/2012
CONTINUING CONNECTED TRANSACTIONS
26/03/2012
Proxy Forms
26/03/2012
Circular-General mandates to issue shares and repurchase its own shares, reelection of directors and adoption of new share option scheme
21/03/2012
Notice of Annual General Meeting
21/03/2012
Final Results Announcement for the year ended 31 December 2011
12/03/2012
TERM SHEET AND POSSIBLE NOTIFIABLE TRANSACTION AND CONNECTED TRANSACTION
07/03/2012
Notice of Board Meeting
01/03/2012
Monthly Return on Movements in Securities for the month ended 29/02/2012
28/02/2012
CONNECTED TRANSACTION- PROVISION OF FINANCIAL ASSISTANCE
01/02/2012
Monthly Return on Movements in Securities for the month ended 31/01/2012
30/01/2012
POSITIVE PROFIT ALERT
03/01/2012
Monthly Return on Movements in Securities for the month ended 31/12/2011
20/12/2011
Grant of options
01/12/2011
Monthly Return on Movements in Securities for the month ended 30/11/2011
28/11/2011
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2011
14/11/2011
Notice of Board Meeting
01/11/2011
Monthly Return on Movements in Securities for the month ended 31/10/2011
20/10/2011
POSITIVE PROFIT ALERT
07/10/2011
Grant of options
03/10/2011
Monthly Return on Movements in Securities for the month ended 30/09/2011
01/09/2011
Monthly Return on Movements in Securities for the month ended 31/08/2011
22/08/2011
Interim Results for the six months ended 30 June 2011
01/08/2011
Monthly Return on Movements in Securities for the month ended 31/07/2011
18/07/2011
CLARIFICATION ANNOUNCEMENT TO PRESS ARTICLE
04/07/2011
Monthly Return on Movements in Securities for the month ended 30/06/2011
01/06/2011
Monthly Return on Movements in Securities for the month ended 31/05/2011
24/05/2011
Next day disclosure returns – issue of share
23/05/2011
First Quarterly Results Announcement for the Three Months Ended 31 March 2011
12/05/2011
Poll Results at Annual General Meeting
09/05/2011
Notice of Board Meeting
03/05/2011
Monthly Return on Movements in Securities for the month ended 30/04/2011
01/04/2011
Next day disclosure returns – issue of share
01/04/2011
Monthly Return on Movements in Securities for the month ended 31/03/2011
24/03/2011
Proxy Forms
24/03/2011
Circular-General mandates to issue shares and repurchase its own shares and reelection of directors
21/03/2011
Notice of Annual General Meeting
21/03/2011
Final Results Announcement for the year ended 31 December 2010
08/03/2011
Notice of Board Meeting
01/03/2011
Monthly Return on Movements in Securities for the month ended 28/02/2011
08/02/2011
Monthly Return on Movements in Securities for the month ended 31/01/2011
06/01/2011
Next day disclosure returns – issue of share
03/01/2011
Monthly Return on Movements in Securities for the month ended 31/12/2010
20/12/2010
Grant of options
07/12/2010
Monthly Return on Movements in Securities for the month ended 30/11/2010
18/11/2010
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2010
05/11/2010
Notice of Board Meeting
01/11/2010
Monthly Return on Movements in Securities for the month ended 31/10/2010
26/10/2010
Next day disclosure returns – issue of share
15/10/2010
Placing of Existing Shares and Top-up Subscription for New Shares under General Mandate and Resumption of Trading
14/10/2010
Suspension of Trading
04/10/2010
Monthly Return on Movements in Securities for the month ended 30/9/2010
06/09/2010
Grant of options
01/09/2010
Monthly Return on Movements in Securities for the month ended 31/8/2010
19/08/2010
Interim Results for the six months ended 30 June 2010
06/08/2010
Notice of Board Meeting
06/08/2010
Monthly Return on Movements in Securities for the month ended 31/7/2010
02/07/2010
Monthly Return on Movements in Securities for the month ended 30/6/2010
01/06/2010
Monthly Return on Movements in Securities for the month ended 31/5/2010
13/05/2010
First Quarterly Results Announcement for the Three Months Ended 31 March 2010
05/05/2010
TRANSFER OF LISTING OF THE SHARES FROM THE GROWTH ENTERPRISE MARKET TO THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED
04/05/2010
MEMORANDUM AND ARTICLES OF ASSOCIATION
03/05/2010
Monthly Return on Movements in Securities for the month ended 30/4/2010
30/04/2010
Poll Results at Annual General Meeting
29/04/2010
Notice of Board Meeting
31/03/2010
Monthly Return on Movements in Securities for the month ended 31/3/2010
10/03/2010
PROPOSED TRANSFER OF LISTING OF THE SHARES FROM THE GROWTH ENTERPRISE MARKET TO THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED
09/03/2010
Proxy Forms
09/03/2010
Circular-General mandates to issue shares and repurchase its own shares, refreshment of the Scheme Mandate Limit of the Share Option Scheme and reelection of directors
05/03/2010
Notice of Annual General Meeting
05/03/2010
Final Results Announcement for the year ended 31 December 2009
01/03/2010
Monthly Return on Movements in Securities for the month ended 28/2/2010
22/02/2010
Notice of Board Meeting
01/02/2010
Company Information Sheet As of 1/2/2010
01/02/2010
Monthly Return on Movements in Securities for the month ended 31/1/2010
14/01/2010
ANNOUNCEMENT ON THE ESTIMATED IMPROVEMENT IN RESULTS FOR THE YEAR ENDED 31 DECEMBER 2009
12/01/2010
Grant of options
04/01/2010
Monthly Return on Movements in Securities for the month ended 31/12/2009
31/12/2009
Company Information Sheet As of 31/12/2009
31/12/2009
Poll Results at Extraordinary General Meeting
15/12/2009
Circular – Continuing Connected Transactions and Discloseable and Connected Transactions
14/12/2009
Proxy Forms
14/12/2009
Notice of Extraordinary General Meeting
04/12/2009
Discloseable and Connected Transactions
01/12/2009
Company Information Sheet As of 30/11/2009
01/12/2009
Monthly Return on Movements in Securities for the month ended 30/11/2009
30/11/2009
Next day disclosure returns – issue of share
24/11/2009
Continuing Connected Transactions
13/11/2009
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2009
03/11/2009
Company Information Sheet As of 3/11/2009
03/11/2009
Monthly Return on Movements in Securities for the month ended 31/10/2009
03/11/2009
Notice of Board Meeting
29/10/2009
Company Information Sheet As of 29/10/2009
29/10/2009
Next day disclosure returns – issue of share
22/10/2009
ANNOUNCEMENT ON THE ESTIMATED IMPROVEMENT IN RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2009
02/10/2009
Monthly Return on Movements in Securities for the month ended 30/09/2009
02/10/2009
Company Information Sheet.
29/09/2009
Next day disclosure returns – issue of share
25/09/2009
Grant of options
01/09/2009
Monthly Return on Movements in Securities for the month ended 31/08/2009
31/08/2009
Company Information Sheet.As of 31/8/2009
27/08/2009
Grant of option
27/08/2009
Next day disclosure returns – issue of share
24/08/2009
Next day disclosure returns – issue of share
24/08/2009
Company Information Sheet. As of 24/8/2009
19/08/2009
Company Information Sheet As of 19/8/2009
19/08/2009
Next day disclosure returns – issue of share
14/08/2009
Next day disclosure returns – issue of share
14/08/2009
Interim Results Announcement for the six months ended 30 June 2009
10/08/2009
Subscription for New Shares
03/08/2009
Monthly Return on Movements in Securities for the month ended 31/07/2009
31/07/2009
Date of board meeting
21/07/2009
ANNOUNCEMENT ON THE ESTIMATED IMPROVEMENT IN 2009 INTERIM RESULTS
02/07/2009
Monthly Return on Movements in Securities for the month ended 30/06/2009
09/06/2009
Company Information Sheet As of 9/6/2009
08/06/2009
Next day disclosure return – issue of share
01/06/2009
Monthly Return on Movements in Securities for the month ended 31/05/2009
19/05/2009
Company Information Sheet.
14/05/2009
First Quarterly Results Announcement for the Three Months Ended 31 March 2009
05/05/2009
Poll Results at Annual General Meeting
04/05/2009
Monthly Return on Movements in Securities for the month ended 30/04/2009
21/04/2009
ANNOUNCEMENT ON THE ESTIMATED IMPROVEMENT IN RESULTS FOR THE FIRST QUARTER OF 2009
01/04/2009
Monthly Return on Movements in Securities for the month ended 31/03/2009
25/03/2009
Proxy Forms
25/03/2009
Circular-General mandates to issue shares and repurchase its own shares and reelection of directors
20/03/2009
Notice of Annual General Meeting
20/03/2009
Final Results Announcement for the year ended 31 December 2008
09/03/2009
Notice of Board Meeting
02/03/2009
Monthly Return on Movements in Securities for the month ended 28/02/2009
03/02/2009
Monthly Return on Movements in Securities for the month ended 31/01/2009
19/01/2009
Announcement on the estimated improvement in results for the year ended 31 December 2008
12/11/2008
Third Quarterly Results Announcement For The Nine Months Ended 30 September 2008
30/10/2008
Notice of Board Meeting
20/10/2008
Announcement on the estimated improvement in results for the nine months ended 30 September 2008
12/08/2008
Interim Results Announcement for the six months ended 30 June 2008
30/07/2008
Notice of Board Meeting
18/07/2008
Announcement on the estimated improvement in 2008 interim results and unusual price and volume movement, resumption of trading
18/07/2008
Suspension of Trading
14/05/2008
Results Announcement (Q1, 2008)
29/04/2008
Notice of Board Meeting
21/04/2008
Announcement on the estimated improvement in results for the first quarter of 2008
25/03/2008
Proxy Form
25/03/2008
Circular – General mandates to issue shares and repurchase its own shares and reelection of directors
20/03/2008
Unusual price and volume movements
18/03/2008
Notice of Annual General Meeting
18/03/2008
Final Results Announcement for the year ended 31 December 2007
05/03/2008
Notice of Board Meeting
22/01/2008
Announcement on the estimated improvement in results for 2007
10/01/2008
Unusual price and volume movements
13/11/2007
Results Announcement (Q3, 2007)
30/10/2007
Notice of Board Meeting
20/09/2007
Exercise of Warrants
13/08/2007
Interim Results 2007
31/07/2007
Notice of Board Meeting
15/06/2007
Unusual Price Movement
14/06/2007
Unusual Price & Volume Movements
13/06/2007
Unusual price & volume movements
29/05/2007
Unusual price & volume movements
11/05/2007
Results Announcement (Q1, 2007)
27/04/2007
Notice of Board Meeting
11/04/2007
Announcement (Clarification announcement)
29/03/2007
Proxy Form
29/03/2007
Circular (General mandates to issue shares and repurchase its own shares, re-election of directors and amendment to articles of association)
23/03/2007
Notice of Annual General Meeting
23/03/2007
Results Announcement (Final, 2006)
12/03/2007
Notice of Board Meeting
01/03/2007
Unusual price & volume movements
26/01/2007
Announcement (Poll results at extraordinary general meeting held on 26 January 2007)
04/01/2007
Proxy Form
04/01/2007
Notice of Extraordinary General Meeting
04/01/2007
Circular (Continuing connected transactions)
13/12/2006
Announcement (Continuing connected transactions)
13/11/2006
Results Announcement (Q3, 2006)
31/10/2006
Notice of Board Meeting
23/10/2006
Announcement (Change of head office and principal place of business)
11/08/2006
Results Announcement (Q2, 2006)
09/08/2006
Unusual price & volume movements
31/07/2006
Notice of Board Meeting
11/05/2006
Results Announcement (Q1, 2006)
24/04/2006
Notice of Board Meeting
30/03/2006
Proxy Form
30/03/2006
Circular (General mandates to issue new shares and repurchase its own shares re-election of directors and amendment to articles of association)
20/03/2006
Notice of Annual General Meeting
20/03/2006
Results Announcement (Final, 2005)
06/03/2006
Notice of Board Meeting
14/12/2005
Unusual price & volume movements
21/11/2005
Unusual price movement
17/11/2005
Unusual price & volume movements
16/11/2005
Unusual price & volume movements
10/11/2005
Results Announcement (Q3, 2005)
21/10/2005
Notice of Board Meeting
13/10/2005
Unusual price & volume movements
22/09/2005
Circular (Discloseable and connected transaction involving acquisition of interests in a sino-foreign equity joint venture company)
08/09/2005
Unusual price & volume movements
30/08/2005
Announcement (Discloseable and connected transaction involving acquisition of interests in a sino-foreign equity joint venture company)
12/08/2005
Results Announcement (Q2, 2005)
08/08/2005
Unusual price movement
29/07/2005
Notice of Board Meeting
28/07/2005
Unusual price movement
07/06/2005
Announcement (Change of qualified accountant and company secretary)
12/05/2005
Results Announcement (Q1, 2005)
04/05/2005
Announcement (Appointment of non-executive director)
26/04/2005
Notice of Board Meeting
31/03/2005
Notice of Annual General Meeting
31/03/2005
Proxy Form
31/03/2005
Circular (General mandates to issue new shares and repurchase its own shares)
23/03/2005
Results Announcement (Final, 2004)
11/03/2005
Announcement (Voting results at extraordinary general meeting held on 11 March 2005)
09/03/2005
Notice of Board Meeting
24/02/2005
Proxy Form
24/02/2005
Circular (Issue of Unlisted Warrants, Renewal of General Mandates to Issue Securities and Repurchase Shares, Increase in Authorized Share Capital and Continuing Connected Transactions)
23/02/2005
Notice of Extraordinary General Meeting
22/02/2005
Announcement (Further delay in despatch of circular)
17/02/2005
Announcement (Further delay in despatch of circular)
03/02/2005
Announcement (Further delay in despatch of circular)
20/01/2005
Announcement (Delay in despatch of circular)
30/12/2004
Announcement (Issue of unlisted warrants, renewal of general mandates to issue securities and repurchase shares, increase in authorized share capital and continuing connected transactions)
05/11/2004
Results Announcement (Q3, 2004)
25/10/2004
Notice of Board Meeting
06/10/2004
Unusual volume movement
16/09/2004
Announcement (Appointment of independent non-executive director)
13/08/2004
Results Announcement (Q2, 2004)
05/08/2004
Announcement (Subscription for new shares and issue of warrants and resumption of trading)
26/07/2004
Notice of Board Meeting
15/07/2004
Announcement (Unusual price & volume movement)
28/06/2004
Announcement (Change of Independent Non-Executive Director and change of Audit Committee)
14/05/2004
Results Announcement (Q1, 2004)
27/04/2004
Notice of Board Meeting
30/03/2004
Circular (General mandates to issue new shares and repurchase its own shares and proposed amendments to the articles of association)
26/03/2004
Notice of Annual General Meeting
25/03/2004
Results Announcement (Final, 2003)
05/03/2004
Notice of Board Meeting
12/02/2004
Announcement (Change of continuing sponsor)
06/02/2004
Announcement (Unusual price & volume movement)
15/01/2004
Announcement (Unusual volume movement)
14/01/2004
Announcement (Clarification announcement)
13/11/2003
Results Announcement (Q3, 2003)
29/10/2003
Notice of Board Meeting
25/09/2003
Announcement (Resignation of executive director and chief marketing officer)
19/09/2003
Announcement (Unusual volume movement)
11/09/2003
Announcement (Unusual volume movement)
27/08/2003
Announcement (Appointment of executive director)
14/08/2003
Results Announcement (Q2, 2003)
30/07/2003
Notice of Board Meeting
03/06/2003
Announcement (Unusual volume movement)
02/06/2003
Announcement (Unusual volume movement)
30/05/2003
Announcement (Unusual volume movement)
14/05/2003
Results Announcement (1Q, 2003)
30/04/2003
Notice of Board Meeting
30/04/2003
Announcement (Unusual volume movement)
31/03/2003
Notice of Annual General Meeting
31/03/2003
Circular (General mandates to issue and repurchase shares)
28/03/2003
Results Announcement (Final, 2002)
17/03/2003
Notice of Board Meeting
10/03/2003
Announcement (Unusual volume movement)
14/11/2002
Results Announcement (3Q, 2002)
31/10/2002
Notice of Board Meeting
14/08/2002
Results Announcement (Q2, 2002)
31/07/2002
Notice of Board Meeting
11/07/2002
Allotment Results
03/07/2002
Formal Notice of IPO
03/07/2002
Prospectus
